Click HERE for Important Information for Licensees struggling with mental health or substance abuse issues.
***SCAM ALERT!!! - All licensees be aware of an ongoing scam. A licensee may receive a call from a person impersonating an investigator, board member, or another government agency official. The call may come from a random cell phone number or spoofing the Division of Professional Regulation’s main phone number of (302) 744-4500. Click HERE for more information.***
If you are unable to reach us by phone, submit your inquiry via email at customerservice.dpr@delaware.gov. More Info
The Delaware Office of Controlled Substances (OCS) is pleased to announce a partnership with Appriss Health to provide interoperability services for all prescribers and pharmacists in Delaware. This service will enable providers to quickly and efficiently access PMP Aware and Narxcare data within their EHR, EMR, or pharmacy dispensing software through the PDMP Gateway® while minimizing interruptions to workflow and patient care.
Currently, prescribers and pharmacists log in to separate systems to query patient data which takes valuable time away from patient care and interaction. This integration simplifies the process by allowing providers to view PMP Aware and Narxcare data directly within their normal workflow without taking any actions. If a provider wishes to see more detail, they simply click on the link provided for instant access.
Integrations must be approved by the PMP Administrator prior to implementation. Providers may apply by following the directions listed below.
The project is funded by a grant from the Centers for Disease Control awarded to the Delaware Division of Public Health and is available through August 2022. If funding becomes no longer available, licensees will be given the option to continue services at their own expense.
Related Topics: Delaware PMP, Delaware Prescription Monitoring Program (PMP), Department of State, professional licensees, professional regulation, State of Delaware